Lindsey Vonn created a monster this past December when she knelt below the medal stand and Tebowed following her World Cup victory. She figured that it was what all the cool kids were doing, and besides, they both lived in Colorado. But from such modest gestures are rampant romance rumors born. Vonn reflected on this during an interview with Access Hollywood Live?s Billy Bush and Kit Hoover, which will air on Thursday.
It?s a cautionary tale, says Vonn, who repeats that she and Tebow are not involved.
?Who knew it could go that fast?? Vonn said.
?He?s a stud? why not date him?? Billy said of Tebow.
?I?m not going to say that,? Lindsey, who is friends with the NFL star?s brother Robby Tebow, said. ?I asked his brother, I got permission. Everyone else just does Tebowing, I actually had permission from family.? Adding with a laugh, ?[Robby] and I were both very surprised that I married [Tim] and had five kids. I didn?t know that could happen so fast.?
There might not be a romance between the athletes, but Lindsey said she?ll continue to be in Tebow?s corner now that he?s playing for the Jets.
?Gotta support the husband,? she joked.
Meanwhile, the Austrian newspaper ?sterreich says it?s found the guy who Vonn is actually dating. According to the paper, Vonn has been seeing Brad Walker, 30, a U.S. pole vaulter trying to make it to the 2012 Olympics.
Austrian newspaper ?sterreich reported discovering what it called the couple?s ?love nest? in the form of a giant white luxury bus parked in a car park at the Planai ski resort where it said the couple had been spending the night together. The paper then tackled the man it said was her lover ? Brad Walker, 30, ? who they described as nervous as they attempted to interview him about his relationship.
*** Lindsey Vonn Lover is a pole vaulter claim [Austrian Times]
The Internet business, retail or otherwise, is much like any other brick and mortar business. It requires a saleable product and service, relevant communication to attract customers, and the backend logistics to deliver the goods. Some people still consider the World Wide Web as an easy maze that will lead them to a `pot of gold'. Let's discuss some key considerations for building a successful retail Internet business.
Research It is important to know if you have any customers, where
The path to personalized cancer treatment Public release date: 28-Mar-2012 [ | E-mail | Share ]
Contact: Aileen Sheehy press.office@sanger.ac.uk 44-012-234-92368 Wellcome Trust Sanger Institute
Researchers identify genetic markers of drug sensitivity in cancer cells
In the largest study of its kind, researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalised approach to cancer treatments. The study is published in Nature on Thursday 29 March 2012.
The team uncovered hundreds of associations between mutations in cancer genes and sensitivity to anticancer drugs. One of the key responses the team found was that cells from a childhood bone cancer, Ewing's sarcoma, respond to a drug that is currently used in the treatment of breast and ovarian cancers. The lowered toxicity of this treatment may mean it is a safer alternative therapy for children and young adults with this aggressive cancer.
There is an intimate relationship between the way a drug works and the genetic changes present in cancers. This study found that sensitivity to most anti-cancer drugs is influenced by mutations in cancer genes and establishes the utility of using large-scale studies to identify these associations and build them into improved patient treatment.
"Our key focus is to find how to use cancer therapeutics in the most effective way by correctly targeting patients that are most likely to respond to a specific therapy," explains Dr Mathew Garnett, first author from the Wellcome Trust Sanger Institute. "We studied how genetic changes in a panel of >600 cancer cell lines effects responses to 130 anti-cancer drugs, making it the largest study of this type to date."
The team identified biological markers of drug sensitivity to a broad range of cancer drugs. Most of the cancer genes analysed, including those that are not known directs targets of the drugs tested, were associated with either sensitivity or resistance to at least one of the drugs analysed.
"Our research has taken us down unknown paths to find associations that are completely novel," says Dr Cyril Benes, senior author from Massachusetts General Hospital Cancer Centre. "We have identified hundreds of associations, many of which we still don't fully understand. We identified a novel indication for the use of PARP inhibitors, anti-cancer drugs currently used to treat breast and ovarian cancers, for the treatment of Ewing's sarcoma."
Ewing's sarcoma is a cancer of children and young adults with a 15% five-year survival rate in patients where the cancer has spread or they have relapsed after chemotherapy. The use of PARP inhibitors could represent a new treatment option for Ewing's sarcoma patients and these compounds will now be tested in clinical trials to assess their therapeutic benefit.
"Advances in next-generation sequencing technologies are already being translated into the large-scale detection of cancer gene mutations in the clinic," says Dr Ultan McDermott, senior author from the Wellcome Trust Sanger Institute. "There is a compelling need to identify, in a systematic fashion, whether observed mutations affect the likelihood of a patient's response to a given drug treatment.
We have therefore developed a unique online open-access resource for the research and medical community that can be used to optimize the clinical application of cancer drugs as well as the design of clinical trials of investigational compounds being developed as treatments."
The team hopes their open-access database will be an important resource for the cancer research community and which will ultimately lead to improved treatments for patients. This research program is a unique Wellcome Trust funded 5-year collaboration between The Cancer Genome Project at the Wellcome Trust Sanger Institute and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center.
"Our work is helping to move cancer therapeutics away from the conventional tissue-based treatment to a more molecular-based treatment," says Professor Daniel Haber, senior author from Massachusetts General Hospital Cancer Centre. "The next steps for this collaborative project are to evaluate some of the key findings using tumour samples and test new candidate therapeutic strategies in clinical trials so we can hopefully improve the way we treat cancer patients. We are continuing our screening effort, in particular using drug combinations to discover innovative and better therapeutic options."
###
Notes to Editors
Publication Details
Garnett et al 'Systematic identification of genomicmarkers of drug sensitivity in cancer cells'
Published in Nature doi:10.1038/nature11005
Funding
This work was supported by a grant from the WellcomeTrust and by grants from the National Institutes of Health. S.R. is supported by a Physician-Scientist Early Career Award from the Howard Hughes Medical Institute. U.M. is supported by a Cancer Research UK Clinician Scientist Fellowship.
Participating Centres
A list of participating centres can be found in the paper
Selected Websites
Massachusetts General Hospital founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $750 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, transplantation biology and photomedicine.
http://www.massgeneral.org
The Wellcome Trust Sanger Institute is one of the world's leading genome centres. Through its ability to conduct research at scale, it is able to engage in bold and long-term exploratory projects that are designed to influence and empower medical science globally.
Institute research findings, generated through its own research programmes and through its leading role in international consortia, are being used to develop new diagnostics and treatments for human disease.
http://www.sanger.ac.uk
The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. We support the brightest minds in biomedical research and the medical humanities. Our breadth of support includes public engagement, education and the application of research to improve health. We are independent of both political and commercial interests.
http://www.wellcome.ac.uk
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
The path to personalized cancer treatment Public release date: 28-Mar-2012 [ | E-mail | Share ]
Contact: Aileen Sheehy press.office@sanger.ac.uk 44-012-234-92368 Wellcome Trust Sanger Institute
Researchers identify genetic markers of drug sensitivity in cancer cells
In the largest study of its kind, researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalised approach to cancer treatments. The study is published in Nature on Thursday 29 March 2012.
The team uncovered hundreds of associations between mutations in cancer genes and sensitivity to anticancer drugs. One of the key responses the team found was that cells from a childhood bone cancer, Ewing's sarcoma, respond to a drug that is currently used in the treatment of breast and ovarian cancers. The lowered toxicity of this treatment may mean it is a safer alternative therapy for children and young adults with this aggressive cancer.
There is an intimate relationship between the way a drug works and the genetic changes present in cancers. This study found that sensitivity to most anti-cancer drugs is influenced by mutations in cancer genes and establishes the utility of using large-scale studies to identify these associations and build them into improved patient treatment.
"Our key focus is to find how to use cancer therapeutics in the most effective way by correctly targeting patients that are most likely to respond to a specific therapy," explains Dr Mathew Garnett, first author from the Wellcome Trust Sanger Institute. "We studied how genetic changes in a panel of >600 cancer cell lines effects responses to 130 anti-cancer drugs, making it the largest study of this type to date."
The team identified biological markers of drug sensitivity to a broad range of cancer drugs. Most of the cancer genes analysed, including those that are not known directs targets of the drugs tested, were associated with either sensitivity or resistance to at least one of the drugs analysed.
"Our research has taken us down unknown paths to find associations that are completely novel," says Dr Cyril Benes, senior author from Massachusetts General Hospital Cancer Centre. "We have identified hundreds of associations, many of which we still don't fully understand. We identified a novel indication for the use of PARP inhibitors, anti-cancer drugs currently used to treat breast and ovarian cancers, for the treatment of Ewing's sarcoma."
Ewing's sarcoma is a cancer of children and young adults with a 15% five-year survival rate in patients where the cancer has spread or they have relapsed after chemotherapy. The use of PARP inhibitors could represent a new treatment option for Ewing's sarcoma patients and these compounds will now be tested in clinical trials to assess their therapeutic benefit.
"Advances in next-generation sequencing technologies are already being translated into the large-scale detection of cancer gene mutations in the clinic," says Dr Ultan McDermott, senior author from the Wellcome Trust Sanger Institute. "There is a compelling need to identify, in a systematic fashion, whether observed mutations affect the likelihood of a patient's response to a given drug treatment.
We have therefore developed a unique online open-access resource for the research and medical community that can be used to optimize the clinical application of cancer drugs as well as the design of clinical trials of investigational compounds being developed as treatments."
The team hopes their open-access database will be an important resource for the cancer research community and which will ultimately lead to improved treatments for patients. This research program is a unique Wellcome Trust funded 5-year collaboration between The Cancer Genome Project at the Wellcome Trust Sanger Institute and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center.
"Our work is helping to move cancer therapeutics away from the conventional tissue-based treatment to a more molecular-based treatment," says Professor Daniel Haber, senior author from Massachusetts General Hospital Cancer Centre. "The next steps for this collaborative project are to evaluate some of the key findings using tumour samples and test new candidate therapeutic strategies in clinical trials so we can hopefully improve the way we treat cancer patients. We are continuing our screening effort, in particular using drug combinations to discover innovative and better therapeutic options."
###
Notes to Editors
Publication Details
Garnett et al 'Systematic identification of genomicmarkers of drug sensitivity in cancer cells'
Published in Nature doi:10.1038/nature11005
Funding
This work was supported by a grant from the WellcomeTrust and by grants from the National Institutes of Health. S.R. is supported by a Physician-Scientist Early Career Award from the Howard Hughes Medical Institute. U.M. is supported by a Cancer Research UK Clinician Scientist Fellowship.
Participating Centres
A list of participating centres can be found in the paper
Selected Websites
Massachusetts General Hospital founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $750 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, transplantation biology and photomedicine.
http://www.massgeneral.org
The Wellcome Trust Sanger Institute is one of the world's leading genome centres. Through its ability to conduct research at scale, it is able to engage in bold and long-term exploratory projects that are designed to influence and empower medical science globally.
Institute research findings, generated through its own research programmes and through its leading role in international consortia, are being used to develop new diagnostics and treatments for human disease.
http://www.sanger.ac.uk
The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. We support the brightest minds in biomedical research and the medical humanities. Our breadth of support includes public engagement, education and the application of research to improve health. We are independent of both political and commercial interests.
http://www.wellcome.ac.uk
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Giving birth is the most important experience of a woman?s life. Her wellbeing, health and emotional state will dictate the kind of birth experience she will have and the child will often reflect characteristic traits of the mother of her mental and emotional state whilst she was pregnant. Doing yoga, meditating, eating a balanced diet and doing the inner work that is required for her to feel in harmony with herself is the greatest gift a mother can give to her child.
Pauline is a Certified Pre-natal Yoga & Meditation Teacher under the study of Gurmukh, the celebrity prenatal yoga teacher in LA. She has ten years experience in teaching yoga and currently teaches classes at high regarded studios throughout Los Angeles and internationally . She has about 8 years experience in holistic nutrition including how to successfully do a vegan/vegetarian pregnancy and she is also 4 months pregnant!
Pauline has a private practice and is available for individual and group private classes in the comfort of your own home or at her studio based in Topanga. SKYPE SESSIONS ARE ALSO AVAILABLE
PRENATAL YOGA AND MEDITATION/ LIFE COACHING/QUANTUM HEALING/ NUTRITIONAL COUNSELING.
FOR MORE INFORMATION CONTACT Pauline:
Website: http://www.theyogaofliving.com/
According to The Onion, Google reportedly shut down its Gmail servers for almost two hours today. Maybe the company is getting tired of its 'nice guy' image? When anyone tried to sign on, they were greeted with the following message instead of access to their email: More »
President Barack Obama speaks at Hankuk University in Seoul, South Korea, March 26, 2012. Obama discussed his Prague agenda to stop the spread of nuclear weapons and seek the peace and security of a world without them.
By msnbc.com staff and news services
Updated 10:20 p.m. ET: President Barack Obama said on Monday the United States can further reduce its nuclear weapons stockpile while maintaining its strategic deterrent.
Obama, speaking at a university in Seoul ahead of global nuclear security summit, said he plans to raise the issue of arms control with Russian President-elect Vladimir Putin when they meet in May.
The president urged North Korean leaders to "have the courage to pursue peace" and warned the country that provocation will not lead to rewards, but to condemnation by the international community. "Those days are over. This is the choice before you," he told students in Seoul.
Obama: North Korean rocket test would isolate regime
Obama also said that time was running out to resolve Iran's nuclear standoff with the west.
Tehran says its nuclear program is purely peaceful, but Israel and Western nations believe it is moving towards a nuclear bomb that could change the regional balance of power.
"Once again, there is the possibility of a diplomatic resolution that gives Iran access to peaceful nuclear energy while addressing the concerns of the international community," Obama told students in Seoul.
"Today, I'll meet with the leaders of Russia and China as we work to achieve a resolution in which Iran fulfills its obligations."
President Obama visited the demilitarized zone between North and South Korea and said China should rein in its communist neighbor. NBC's Kristen Welker reports.
?
Obama calls Korean DMZ 'Freedom's frontier'
Obama will rely on China to work with North Korea, the Washington Post reported. The president has called nuclear terrorism the United States? biggest threat, according to the Post, and North Korea could prove to be a grave issue.
The Associated Press and Reuters contributed to this report.
A house extension is actually one of the best investments you can make. The beauty of a new loft conversion, a renovated garage or basement or even a newly built conservatory cannot be matched by anything. The satisfaction it brings you is unparalleled. The beauty of your home can be a testament to your happiness, contentment and success. Even if you do not have a lot of money, a beautiful home is enough for you to feel successful.
But do not think that you are only spending money on hiring builders and having your home converted. Adding space and having a loft conversion is actually rewarding. It can increase the value of your home. Should you decide to sell it in the future, you will not have a hard time doing so. A lot of buyers prefer houses with room extensions. They will go the extra mile to acquire. Homes with house extensions in Bristol can be easily sold in the market at a very reasonable price so you can actually make profit out of it.
Before hiring Bristol builders, find out what the best remodelling idea is suitable for your home first. A highly recommended extension is a conservatory. This can also be called a sun room. A conservatory is an extra room in the house surrounded with lots of windows. This is going to be one of the breeziest and sunniest places in the house. It can be turned into an extra living room, a study room, a recreation room or even an inspiration room. If you are fond of going on vacations, this is also a good investment. You do not have to go far to get much needed rest and relaxation. You can simply enjoy your staycation in your conservatory.
Another wonderful home extensions idea is a loft conversion. ?Your loft can be turned into an extra bedroom for guests. For those people with a growing family, you can easily transform this to a room that can be used by your additional family member. Parents can also turn their loft into a recreation room for their kids. Put your entertainment centre here or turn this into a study area. Kids will definitely appreciate the privacy that this room can give them.
Home remodelling does not always have to mean adding extra rooms or extension rooms. You can hire Bristol builders just to have your existing rooms re made or re fitted. This is actually a good idea if you are on a limited budget. Hire builders to transform your ordinary bathroom into a luxurious one. Never underestimate a beautiful bathroom. It can actually increase your comfort and get rid of stress. To modern day people, this is definitely priceless.
For kitchen lovers, have your kitchen refitted. Builders can change countertops, tiles and cabinet. Get rid of your old rickety overhead cabinets and have the whole kitchen transformed by opting for more reliable wooden cabinets. You can also have your very own kitchen island installed for your cooking comfort.
Garages, these days, are not only used to store cars. Many people also use this as an extra storage room. But do not just stop there. Do not scatter your home decorating equipment in the garage. Turn this into a beautiful living space as well. Have the builder create division in the garage so you have space for your car and ample space for seating areas. With home interior design and decoration, you can turn this into a two in one room.
If you like organizing parties or throwing parties in your home, a conservatory turned into a kitchen should be a wonderful house extension or home remodelling idea. Sun coming in the room and making your airy kitchen look light and fresh is indeed a balm to the spirit. You can use this room not only to cook but to entertain friends and guests as well.
There are actually a lot of house extensions Bristol ideas that you can try. It is important to know how to invest your money properly. Do not just spend on meaningless expenditures. Make sure your investments offer permanent results. Consider hiring Bristol builders to have loft conversion Bristol or any kind of home remodelling idea you have in mind.
![[ Back to EurekAlert! ]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vzAZqbVwEOFttu2-kO2yBINmhczzBtdtzqRIBCLG95U7aOjPw--iHLDi4w8KzS6sx0WaH5s9L5xju5i1-K5yiAjUBtlrhLgoWMEcH_t_U=s0-d){kind=small}
Public release date: 28-Mar-2012
Share ] 
